Hostname: page-component-7b7567c8c-lpg2g Total loading time: 0 Render date: 2026-11-15T12:23:57.376Z Has data issue: false hasContentIssue false

The impact of an antimicrobial stewardship program restriction on remdesivir prescribing

Published online by Cambridge University Press:  31 August 2022

Kristen E. Zeitler*
Affiliation:
Department of Pharmacy, Tampa General Hospital, Tampa, Florida
Nicholas Piccicacco
Affiliation:
Department of Pharmacy, Tampa General Hospital, Tampa, Florida
Ripal Jariwala
Affiliation:
Department of Pharmaceutical Services, University of California San Francisco, San Francisco, California
Jose Montero
Affiliation:
Division of Infectious Diseases, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida
Kami Kim
Affiliation:
Division of Infectious Diseases, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FloridaGlobal Emerging Diseases Institute, Tampa General Hospital, Tampa, Florida
*
Author for correspondence: Kristen E. Zeitler, PharmD, Department of Pharmacy, Tampa General Hospital, 1 Tampa General Circle, Tampa, FL 33606. E-mail: kzeitler@tgh.org

Abstract

Information

Type
Letter to the Editor
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America.
Figure 0

Figure 1.Institutional Remdesivir Ordering Restriction Algorithm.